This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Alcoba-Flórez J, Méndez-Alvarez S, Cano J, Guarro J, Pérez-Roth E, del Pilar Arévalo M. Phenotypic and molecular characterization of Candida nivariensis sp. nov., a possible new opportunistic fungus. J Clin Microbiol. 2005;43(8):4107–4111. https:/doi.org/10.1128/JCM.43.8.4107-4111.2005Alcoba-FlórezJMéndez-AlvarezSCanoJGuarroJPérez-RothEdel Pilar ArévaloMPhenotypic and molecular characterization of Candida nivariensis sp. nov., a possible new opportunistic fungus. J Clin Microbiol. 2005;43(8):4107–4111. https:/doi.org/10.1128/JCM.43.8.4107-4111.200510.1128/JCM.43.8.4107-4111.2005123398616081957Search in Google Scholar
Alexander BD, Johnson MD, Pfeiffer CD, Jiménez-Ortigosa C, Catania J, Booker R, Castanheira M, Messer SA, Perlin DS, Pfaller MA. Increasing echinocandin resistance in Candida glabrata: clinical failure correlates with presence of FKS mutations and elevated minimum inhibitory concentrations. Clin Infect Dis. 2013;56(12):1724–1732. https:/doi.org/10.1093/cid/cit136AlexanderBDJohnsonMDPfeifferCDJiménez-OrtigosaCCataniaJBookerRCastanheiraMMesserSAPerlinDSPfallerMAIncreasing echinocandin resistance in Candida glabrata: clinical failure correlates with presence of FKS mutations and elevated minimum inhibitory concentrations. Clin Infect Dis. 2013;56(12):1724–1732. https:/doi.org/10.1093/cid/cit13610.1093/cid/cit136365836323487382Search in Google Scholar
Angoulvant A, Guitard J, Hennequin C. Old and new pathogenic Nakaseomyces species: epidemiology, biology, identification, pathogenicity and antifungal resistance. FEMS Yeast Res. 2016;16(2):fov114.AngoulvantAGuitardJHennequinCOld and new pathogenic Nakaseomyces species: epidemiology, biology, identification, pathogenicity and antifungal resistance. FEMS Yeast Res.2016;16(2):fov114.10.1093/femsyr/fov11426691882Search in Google Scholar
Arendrup MC, Dzajic E, Jensen RH, Johansen HK, Kjaldgaard P, Knudsen JD, Kristensen L, Leitz C, Lemming LE, Nielsen L, et al. Epidemiological changes with potential implication for antifungal prescription recommendations for fungaemia: data from a nationwide fungaemia surveillance programme. Clin Microbiol Infect. 2013;19(8):e343–e353. https:/doi.org/10.1111/1469-0691.12212ArendrupMCDzajicEJensenRHJohansenHKKjaldgaardPKnudsenJDKristensenLLeitzCLemmingLENielsenLet al.Epidemiological changes with potential implication for antifungal prescription recommendations for fungaemia: data from a nationwide fungaemia surveillance programme. Clin Microbiol Infect. 2013;19(8):e343–e353. https:/doi.org/10.1111/1469-0691.1221210.1111/1469-0691.1221223607326Search in Google Scholar
Bassetti M, Ansaldi F, Nicolini L, Malfatto E, Molinari MP, Mussap M, Rebesco B, Bobbio Pallavicini F, Icardi G, Viscoli C. Incidence of candidaemia and relationship with fluconazole use in an intensive care unit. J Antimicrob Chemother. 2009;64(3):625–629. https:/doi.org/10.1093/jac/dkp251BassettiMAnsaldiFNicoliniLMalfattoEMolinariMPMussapMRebescoBBobbio PallaviciniFIcardiGViscoliCIncidence of candidaemia and relationship with fluconazole use in an intensive care unit. J Antimicrob Chemother. 2009;64(3):625–629. https:/doi.org/10.1093/jac/dkp25110.1093/jac/dkp25119622536Search in Google Scholar
Bishop JA, Chase N, Lee R, Kurtzman CP, Merz WG. Production of white colonies on CHROMagar Candida medium by members of the Candida glabrata clade and other species with overlapping phenotypic traits. J Clin Microbiol. 2008;46(10):3498–3500. https:/doi.org/10.1128/JCM.00982-08BishopJAChaseNLeeRKurtzmanCPMerzWGProduction of white colonies on CHROMagar Candida medium by members of the Candida glabrata clade and other species with overlapping phenotypic traits. J Clin Microbiol. 2008;46(10):3498–3500. https:/doi.org/10.1128/JCM.00982-0810.1128/JCM.00982-08256606518685009Search in Google Scholar
Borman AM, Petch R, Linton CJ, Palmer MD, Bridge PD, Johnson EM. Candida nivariensis, an emerging pathogenic fungus with multidrug resistance to antifungal agents. J Clin Microbiol. 2008; 46(3):933–938. https:/doi.org/10.1128/JCM.02116-07BormanAMPetchRLintonCJPalmerMDBridgePDJohnsonEMCandida nivariensis, an emerging pathogenic fungus with multidrug resistance to antifungal agents. J Clin Microbiol. 2008; 46(3):933–938. https:/doi.org/10.1128/JCM.02116-0710.1128/JCM.02116-07226833218199788Search in Google Scholar
Chowdhary A, Randhawa HS, Khan ZU, Ahmad S, Juneja S, Sharma B, Roy P, Sundar G, Joseph L. First isolations in India of Candida nivariensis, a globally emerging opportunistic pathogen. Med Mycol. 2010;48(2):416–420. https:/doi.org/10.3109/13693780903114231ChowdharyARandhawaHSKhanZUAhmadSJunejaSSharmaBRoyPSundarGJosephLFirst isolations in India of Candida nivariensis, a globally emerging opportunistic pathogen. Med Mycol.2010;48(2):416–420. https:/doi.org/10.3109/1369378090311423110.3109/13693780903114231Search in Google Scholar
Cleary JD, Garcia-Effron G, Chapman SW, Perlin DS. Reduced Candida glabrata susceptibility secondary to an FKS1 mutation developed during candidemia treatment. Antimicrob Agents Chemother. 2008;52(6):2263–2265. https:/doi.org/10.1128/AAC.01568-07ClearyJDGarcia-EffronGChapmanSWPerlinDSReduced Candida glabrata susceptibility secondary to an FKS1 mutation developed during candidemia treatment. Antimicrob Agents Chemother. 2008;52(6):2263–2265. https:/doi.org/10.1128/AAC.01568-0710.1128/AAC.01568-07241579218378714Search in Google Scholar
Cleveland AA, Harrison LH, Farley MM, Hollick R, Stein B, Chiller TM, Lockhart SR, Park BJ. Declining incidence of candidemia and the shifting epidemiology of Candida resistance in two US metropolitan areas, 2008–2013: results from population-based surveillance. PLoS One. 2015;10(3):e0120452. https:/doi.org/10.1371/journal.pone.0120452ClevelandAAHarrisonLHFarleyMMHollickRSteinBChillerTMLockhartSRParkBJDeclining incidence of candidemia and the shifting epidemiology of Candida resistance in two US metropolitan areas, 2008–2013: results from population-based surveillance. PLoS One. 2015;10(3):e0120452. https:/doi.org/10.1371/journal.pone.012045210.1371/journal.pone.0120452437885025822249Search in Google Scholar
CLSI. Reference method for broth dilution antifungal susceptibility testing of yeasts. Standard M27-A3. Wayne (USA): Clinical and Laboratory Standards Institute; 2008.CLSIReference method for broth dilution antifungal susceptibility testing of yeasts. Standard M27-A3. Wayne (USA): Clinical and Laboratory Standards Institute; 2008.Search in Google Scholar
Colombo AL, Garnica M, Aranha Camargo LF, Da Cunha CA, Bandeira AC, Borghi D, Campos T, Senna AL, Valias Didier ME, Dias VC, et al. Candida glabrata: an emerging pathogen in Brazilian tertiary care hospitals. Med Mycol. 2013;51(1):38–44. https:/doi.org/10.3109/13693786.2012.698024ColomboALGarnicaMAranha CamargoLFDa CunhaCABandeiraACBorghiDCamposTSennaALValias DidierMEDiasVCet al.Candida glabrata: an emerging pathogen in Brazilian tertiary care hospitals. Med Mycol.2013;51(1):38–44. https:/doi.org/10.3109/13693786.2012.69802410.3109/13693786.2012.698024Search in Google Scholar
EUCAST. Clinical breakpoints for fungi v 9.0 [Internet]. Basel (Switzerland): The European Committee on Antimicrobial Susceptibility Testing; [cited 2019 Feb 01]. 2018. Available from: http://www.eucast.org/fileadmin/src/media/PDFs/EUCAST_files/AFST/Clinical_breakpoints/Antifungal_breakpoints_v_9.0_180212.pdfEUCASTClinical breakpoints for fungi v 9.0 [Internet]. Basel (Switzerland): The European Committee on Antimicrobial Susceptibility Testing; [cited 2019 Feb 01]. 2018. Available from: http://www.eucast.org/fileadmin/src/media/PDFs/EUCAST_files/AFST/Clinical_breakpoints/Antifungal_breakpoints_v_9.0_180212.pdfSearch in Google Scholar
Falagas ME, Roussos N, Vardakas KZ. Relative frequency of albicans and the various non-albicans Candida spp. among candidemia isolates from inpatients in various parts of the world: a systematic review. Int J Infect Dis. 2010;14(11):e954–e966. https:/doi.org/10.1016/j.ijid.2010.04.006FalagasMERoussosNVardakasKZRelative frequency of albicans and the various non-albicans Candida spp. among candidemia isolates from inpatients in various parts of the world: a systematic review. Int J Infect Dis. 2010;14(11):e954–e966. https:/doi.org/10.1016/j.ijid.2010.04.00610.1016/j.ijid.2010.04.006Search in Google Scholar
Fujita S, Senda Y, Okusi T, Ota Y, Takada H, Yamada K, Kawano M. Catheter-related fungemia due to fluconazole-resistant Candida nivariensis. J Clin Microbiol. 2007;45(10):3459–3461. https:/doi.org/10.1128/JCM.00727-07FujitaSSendaYOkusiTOtaYTakadaHYamadaKKawanoMCatheter-related fungemia due to fluconazole-resistant Candida nivariensis.J Clin Microbiol. 2007;45(10):3459–3461. https:/doi.org/10.1128/JCM.00727-0710.1128/JCM.00727-07Search in Google Scholar
Garcia-Effron G, Park S, Perlin DS. Correlating echinocandin MIC and kinetic inhibition of fks1 mutant glucan synthases for Candida albicans: implications for interpretive breakpoints. Antimicrob Agents Chemother. 2009;53(1):112–122. https:/doi.org/10.1128/AAC.01162-08Garcia-EffronGParkSPerlinDSCorrelating echinocandin MIC and kinetic inhibition of fks1 mutant glucan synthases for Candida albicans: implications for interpretive breakpoints. Antimicrob Agents Chemother. 2009;53(1):112–122. https:/doi.org/10.1128/AAC.01162-0810.1128/AAC.01162-08Search in Google Scholar
Gołaś M, Netsvyetayeva I, Sikora M, Piskorska K, Sulik-Tyszka B, Swoboda-Kopeć E. Trends in antifungal susceptibility of Candida species – one year observation. Pol J Microbiol. 2014;63(2):217–222.GołaśMNetsvyetayevaISikoraMPiskorskaKSulik-TyszkaBSwoboda-KopećETrends in antifungal susceptibility of Candida species – one year observation. Pol J Microbiol. 2014;63(2):217–222.10.33073/pjm-2014-028Search in Google Scholar
Guinea J. Global trends in the distribution of Candida species causing candidemia. Clin Microbiol Infect. 2014;20 Suppl 6:5–10. https:/doi.org/10.1111/1469-0691.12539GuineaJGlobal trends in the distribution of Candida species causing candidemia. Clin Microbiol Infect. 2014;20Suppl 6:5–10. https:/doi.org/10.1111/1469-0691.1253910.1111/1469-0691.12539Search in Google Scholar
Hou X, Xiao M, Chen SCA, Wang H, Yu SY, Fan X, Kong F, Xu YC. Identification and Antifungal Susceptibility Profiles of Candida nivariensis and Candida bracarensis in a Multi-Center Chinese Collection of Yeasts. Front Microbiol. 2017;8:5. https:/doi.org/10.3389/fmicb.2017.00005HouXXiaoMChenSCAWangHYuSYFanXKongFXuYCIdentification and Antifungal Susceptibility Profiles of Candida nivariensis and Candida bracarensis in a Multi-Center Chinese Collection of Yeasts. Front Microbiol. 2017;8:5. https:/doi.org/10.3389/fmicb.2017.0000510.3389/fmicb.2017.00005Search in Google Scholar
Katiyar S, Pfaller M, Edlind T. Candida albicans and Candida glabrata clinical isolates exhibiting reduced echinocandin susceptibility. Antimicrob Agents Chemother. 2006;50(8):2892–2894. https:/doi.org/10.1128/AAC.00349-06KatiyarSPfallerMEdlindTCandida albicans and Candida glabrata clinical isolates exhibiting reduced echinocandin susceptibility. Antimicrob Agents Chemother. 2006;50(8):2892–2894. https:/doi.org/10.1128/AAC.00349-0610.1128/AAC.00349-06Search in Google Scholar
Kurtzman C, Robnett C. Phylogenetic relationships among yeasts of the ‘Saccharomyces complex’ determined from multigene sequence analyses. FEMS Yeast Res. 2003;3(4):417–432. https:/doi.org/10.1016/S1567-1356(03)00012-6KurtzmanCRobnettCPhylogenetic relationships among yeasts of the ‘Saccharomyces complex’ determined from multigene sequence analyses. FEMS Yeast Res.2003;3(4):417–432. https:/doi.org/10.1016/S1567-1356(03)00012-610.1016/S1567-1356(03)00012-6Search in Google Scholar
Li J, Shan Y, Fan S, Liu X. Prevalence of Candida nivariensis and Candida bracarensis in vulvovaginal Candidiasis. Mycopathologia. 2014;178(3-4): 279–283. https:/doi.org/10.1007/s11046-014-9800-2LiJShanYFanSLiuXPrevalence of Candida nivariensis and Candida bracarensis in vulvovaginal Candidiasis. Mycopathologia. 2014;178(3-4): 279–283. https:/doi.org/10.1007/s11046-014-9800-210.1007/s11046-014-9800-225118875Search in Google Scholar
Lockhart SR, Iqbal N, Cleveland AA, Farley MM, Harrison LH, Bolden CB, Baughman W, Stein B, Hollick R, Park BJ, et al. Species identification and antifungal susceptibility testing of Candida bloodstream isolates from population-based surveillance studies in two U.S. cities from 2008 to 2011. J Clin Microbiol. 2012;50(11): 3435–3442. https:/doi.org/10.1128/JCM.01283-12LockhartSRIqbalNClevelandAAFarleyMMHarrisonLHBoldenCBBaughmanWSteinBHollickRParkBJet alSpecies identification and antifungal susceptibility testing of Candida bloodstream isolates from population-based surveillance studies in two U.S. cities from 2008 to 2011. J Clin Microbiol. 2012;50(11): 3435–3442. https:/doi.org/10.1128/JCM.01283-1210.1128/JCM.01283-12348621122875889Search in Google Scholar
Lockhart SR, Messer SA, Gherna M, Bishop JA, Merz WG, Pfaller MA, Diekema DJ. Identification of Candida nivariensis and Candida bracarensis in a large global collection of Candida glabrata isolates: comparison to the literature. J Clin Microbiol. 2009; 47(4):1216–1217. https:/doi.org/10.1128/JCM.02315-08LockhartSRMesserSAGhernaMBishopJAMerzWGPfallerMADiekemaDJIdentification of Candida nivariensis and Candida bracarensis in a large global collection of Candida glabrata isolates: comparison to the literature. J Clin Microbiol. 2009; 47(4):1216–1217. https:/doi.org/10.1128/JCM.02315-0810.1128/JCM.02315-08266831919193845Search in Google Scholar
Miranda-Zapico I, Eraso E, Hernández-Almaraz JL, López-Soria LM, Carrillo-Muñoz AJ, Hernández-Molina JM, Quindós G. Prevalence and antifungal susceptibility patterns of new cryptic species inside the species complexes Candida parapsilosis and Candida glabrata among blood isolates from a Spanish tertiary hospital. J Antimicrob Chemother. 2011;66(10):2315–2322. https:/doi.org/10.1093/jac/dkr298Miranda-ZapicoIErasoEHernández-AlmarazJLLópez-SoriaLMCarrillo-MuñozAJHernández-MolinaJMQuindósGPrevalence and antifungal susceptibility patterns of new cryptic species inside the species complexes Candida parapsilosis and Candida glabrata among blood isolates from a Spanish tertiary hospital. J Antimicrob Chemother. 2011;66(10):2315–2322. https:/doi.org/10.1093/jac/dkr29810.1093/jac/dkr29821795259Search in Google Scholar
Morales-López S, Dudiuk C, Vivot W, Szusz W, Córdoba SB, Garcia-Effron G. Phenotypic and molecular evaluation of echinocandin susceptibility of Candida glabrata, Candida bracarensis, and Candida nivariensis strains isolated during 30 years in Argentina. Antimicrob Agents Chemother. 2017;61(7):e00170-17. https:/doi.org/10.1128/AAC.00170-17Morales-LópezSDudiukCVivotWSzuszWCórdobaSBGarcia-EffronGPhenotypic and molecular evaluation of echinocandin susceptibility of Candida glabrataCandida bracarensis, and Candida nivariensis strains isolated during 30 years in Argentina. Antimicrob Agents Chemother. 2017;61(7):e00170-17. https:/doi.org/10.1128/AAC.00170-1710.1128/AAC.00170-17548763128461313Search in Google Scholar
Panackal AA, Gribskov JL, Staab JF, Kirby KA, Rinaldi M, Marr KA. Clinical significance of azole antifungal drug cross-resistance in Candida glabrata. J Clin Microbiol. 2006;44(5):1740–1743. https:/doi.org/10.1128/JCM.44.5.1740-1743.2006PanackalAAGribskovJLStaabJFKirbyKARinaldiMMarrKAClinical significance of azole antifungal drug cross-resistance in Candida glabrata.J Clin Microbiol. 2006;44(5):1740–1743. https:/doi.org/10.1128/JCM.44.5.1740-1743.200610.1128/JCM.44.5.1740-1743.2006147921216672401Search in Google Scholar
Pfaller MA, Messer SA, Boyken L, Tendolkar S, Hollis RJ, Diekema DJ. Geographic variation in the susceptibilities of invasive isolates of Candida glabrata to seven systemically active antifungal agents: a global assessment from the ARTEMIS Antifungal Surveillance Program conducted in 2001 and 2002. J Clin Microbiol. 2004;42(7):3142–3146. https:/doi.org/10.1128/JCM.42.7.3142-3146.2004PfallerMAMesserSABoykenLTendolkarSHollisRJDiekemaDJGeographic variation in the susceptibilities of invasive isolates of Candida glabrata to seven systemically active antifungal agents: a global assessment from the ARTEMIS Antifungal Surveillance Program conducted in 2001 and 2002. J Clin Microbiol. 2004;42(7):3142–3146. https:/doi.org/10.1128/JCM.42.7.3142-3146.200410.1128/JCM.42.7.3142-3146.200444624815243073Search in Google Scholar
Pfaller MA, Moet GJ, Messer SA, Jones RN, Castanheira M. Geographic variations in species distribution and echinocandin and azole antifungal resistance rates among Candida bloodstream infection isolates: report from the SENTRY Antimicrobial Surveillance Program (2008 to 2009). J Clin Microbiol. 2011;49(1):396–399. https:/doi.org/10.1128/JCM.01398-10PfallerMAMoetGJMesserSAJonesRNCastanheiraMGeographic variations in species distribution and echinocandin and azole antifungal resistance rates among Candida bloodstream infection isolates: report from the SENTRY Antimicrobial Surveillance Program (2008 to 2009). J Clin Microbiol. 2011;49(1):396–399. https:/doi.org/10.1128/JCM.01398-1010.1128/JCM.01398-10302043621068282Search in Google Scholar
Quindós G. Epidemiology of candidaemia and invasive candidiasis. A changing face. Rev Iberoam Micol. 2014;31(1):42–48. https:/doi.org/10.1016/j.riam.2013.10.001QuindósGEpidemiology of candidaemia and invasive candidiasis. A changing face. Rev Iberoam Micol. 2014;31(1):42–48. https:/doi.org/10.1016/j.riam.2013.10.00110.1016/j.riam.2013.10.00124270071Search in Google Scholar
Rodrigues CF, Silva S, Henriques M. Candida glabrata: a review of its features and resistance. Eur J Clin Microbiol Infect Dis. 2014; 33(5):673–688. https:/doi.org/10.1007/s10096-013-2009-3RodriguesCFSilvaSHenriquesMCandida glabrata: a review of its features and resistance. Eur J Clin Microbiol Infect Dis. 2014; 33(5):673–688. https:/doi.org/10.1007/s10096-013-2009-310.1007/s10096-013-2009-324249283Search in Google Scholar
Sharma C, Wankhede S, Muralidhar S, Prakash A, Singh PK, Kathuria S, Kumar DA, Khan N, Randhawa HS, Meis JF, et al. Candida nivariensis as an etiologic agent of vulvovaginal candidiasis in a tertiary care hospital of New Delhi, India. Diagn Microbiol Infect Dis. 2013;76(1):46–50. https:/doi.org/10.1016/j.diagmicrobio.2013.02.023SharmaCWankhedeSMuralidharSPrakashASinghPKKathuriaSKumarDAKhanNRandhawaHSMeisJFet alCandida nivariensis as an etiologic agent of vulvovaginal candidiasis in a tertiary care hospital of New Delhi, India. Diagn Microbiol Infect Dis.2013;76(1):46–50. https:/doi.org/10.1016/j.diagmicrobio.2013.02.02310.1016/j.diagmicrobio.2013.02.02323537782Search in Google Scholar
Silva S, Negri M, Henriques M, Oliveira R, Williams DW, Azeredo J. Candida glabrata, Candida parapsilosis and Candida tropicalis: biology, epidemiology, pathogenicity and antifungal resistance. FEMS Microbiol Rev. 2012;36(2):288–305. https:/doi.org/10.1111/j.1574-6976.2011.00278.xSilvaSNegriMHenriquesMOliveiraRWilliamsDWAzeredoJCandida glabrata, Candida parapsilosis and Candida tropicalis: biology, epidemiology, pathogenicity and antifungal resistance. FEMS Microbiol Rev. 2012;36(2):288–305. https:/doi.org/10.1111/j.1574-6976.2011.00278.x10.1111/j.1574-6976.2011.00278.x21569057Search in Google Scholar
Tamura NK, Negri MFN, Bonassoli LA, Svidzinski TIE. [Virulence factors for Candida spp. recovered from intravascular catheters and hospital workers hands] (in Portuguese). Rev Soc Bras Med Trop. 2007;40(1):91–93. https:/doi.org/10.1590/S0037-86822007000100021TamuraNKNegriMFNBonassoliLASvidzinskiTIE[Virulence factors for Candida spp. recovered from intravascular catheters and hospital workers hands] (in Portuguese). Rev Soc Bras Med Trop. 2007;40(1):91–93. https:/doi.org/10.1590/S0037-8682200700010002110.1590/S0037-8682200700010002117486265Search in Google Scholar
Tapia GG, Razonable RR, Eckel-Passow JE, Lahr BD, Afessa B, Keegan MT, Catania J, Baddour LM. A scoring model of factors associated with Candida glabrata candidemia among critically ill patients. Mycoses. 2012;55(3):228–236. https:/doi.org/10.1111/j.1439-0507.2011.02069.xTapiaGGRazonableRREckel-PassowJELahrBDAfessaBKeeganMTCataniaJBaddourLMA scoring model of factors associated with Candida glabrata candidemia among critically ill patients. Mycoses. 2012;55(3):228–236. https:/doi.org/10.1111/j.1439-0507.2011.02069.x10.1111/j.1439-0507.2011.02069.x21777296Search in Google Scholar
Tay ST, Lotfalikhani A, Sabet NS, Ponnampalavanar S, Sulaiman S, Na SL, Ng KP. Occurrence and characterization of Candida nivariensis from a culture collection of Candida glabrata clinical isolates in Malaysia. Mycopathologia. 2014;178(3-4): 307–314. https:/doi.org/10.1007/s11046-014-9778-9TaySTLotfalikhaniASabetNSPonnampalavanarSSulaimanSNaSLNgKPOccurrence and characterization of Candida nivariensis from a culture collection of Candida glabrata clinical isolates in Malaysia. Mycopathologia. 2014;178(3-4): 307–314. https:/doi.org/10.1007/s11046-014-9778-910.1007/s11046-014-9778-925022264Search in Google Scholar
Thompson GR 3rd, Wiederhold NP, Vallor AC, Villareal NC, Lewis JS 2nd, Patterson TF. Development of caspofungin resistance following prolonged therapy for invasive candidiasis secondary to Candida glabrata infection. Antimicrob Agents Chemother. 2008;52(10):3783–3785. https:/doi.org/10.1128/AAC.00473-08ThompsonGR3rdWiederholdNPVallorACVillarealNCLewisJS 2nd, PattersonTFDevelopment of caspofungin resistance following prolonged therapy for invasive candidiasis secondary to Candida glabrata infection. Antimicrob Agents Chemother. 2008;52(10):3783–3785. https:/doi.org/10.1128/AAC.00473-0810.1128/AAC.00473-08256591918676885Search in Google Scholar
